Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.
about
Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma?In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150GluedIntrinsic gene changes determine the successful establishment of stable renal cancer cell lines from tumor tissue.Effect of Duration of Ex Vivo Ischemia Time and Storage Period on RNA Quality in Biobanked Human Renal Cell Carcinoma Tissue.Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma.Circulating Tumor Cells for the Management of Renal Cell Carcinoma
P2860
Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Neoadjuvant sorafenib treatmen ...... f circulating tumor fragments.
@ast
Neoadjuvant sorafenib treatmen ...... f circulating tumor fragments.
@en
type
label
Neoadjuvant sorafenib treatmen ...... f circulating tumor fragments.
@ast
Neoadjuvant sorafenib treatmen ...... f circulating tumor fragments.
@en
prefLabel
Neoadjuvant sorafenib treatmen ...... f circulating tumor fragments.
@ast
Neoadjuvant sorafenib treatmen ...... f circulating tumor fragments.
@en
P2093
P2860
P1433
P1476
Neoadjuvant sorafenib treatmen ...... f circulating tumor fragments.
@en
P2093
Carla van Herpen
Cathy Maass
Christina Hulsbergen-van de Kaa
Egbert Oosterwijk
Gursah Kats-Ugurlu
Ingrid Desar
Jeannette Oosterwijk-Wakka
Mirjam de Weijert
Peter Mulders
Rob de Waal
P2860
P304
P356
10.1016/J.NEO.2014.03.007
P577
2014-03-01T00:00:00Z